TScan Therapeutics, Inc.
TCRX
$1.07
$0.021.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.37% | -15.41% | -13.37% | -13.24% | 7.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 29.36% | 20.32% | -1.97% | 20.48% | -11.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.45% | -14.91% | -13.23% | -12.94% | 6.80% |
|
|
|||||
| Total Current Assets | -16.45% | -14.91% | -13.23% | -12.94% | 6.80% |
| Net Property, Plant & Equipment | -3.33% | -2.66% | -0.66% | -0.72% | 6.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.52% | -21.93% | 0.40% | -0.16% | -0.60% |
| Total Assets | -12.75% | -12.17% | -10.26% | -10.35% | 6.63% |
|
|
|||||
| Total Accounts Payable | -80.47% | 39.96% | -8.60% | 16.08% | 17.30% |
| Total Accrued Expenses | -29.35% | -16.11% | 33.96% | -38.63% | 40.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.81% | 9.80% | 26.49% | 8.77% | 17.24% |
| Total Finance Division Other Current Liabilities | -47.63% | -31.86% | -24.65% | -11.09% | 15.64% |
| Total Other Current Liabilities | -47.63% | -31.86% | -24.65% | -11.09% | 15.64% |
| Total Current Liabilities | -35.99% | -6.75% | 5.05% | -17.08% | 25.46% |
|
|
|||||
| Total Current Liabilities | -35.99% | -6.75% | 5.05% | -17.08% | 25.46% |
| Long-Term Debt | 0.37% | 0.37% | 0.35% | 0.34% | 4.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.32% | -3.12% | -2.95% | -1.41% | 8.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 146.02% | -81.92% | -54.74% | -63.87% |
| Total Liabilities | -10.61% | -2.99% | -0.54% | -5.87% | 9.42% |
|
|
|||||
| Common Stock & APIC | 0.33% | 0.48% | 0.56% | 0.55% | 8.38% |
| Retained Earnings | -4.77% | -8.00% | -9.03% | -9.10% | -10.55% |
| Treasury Stock & Other | -- | 150.00% | 0.00% | -107.84% | -- |
| Total Common Equity | -14.51% | -18.50% | -15.93% | -12.77% | 5.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.51% | -18.50% | -15.93% | -12.77% | 5.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.51% | -18.50% | -15.93% | -12.77% | 5.19% |
|
|
|||||